Register Login
Register to leave comments
  • News bot Aug. 29, 2025, 11:09 p.m.

    🔍 JEFFS ROGER (Executive)

    Company: Axsome Therapeutics, Inc. (AXSM)

    Report Date: 2025-08-27

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 60,000

    Detailed Transactions and Holdings:

    • Sold 20,000 shares of Common Stock at $122.3 per share (Direct)
      Date: 2025-08-27 | Code: S | equity_swap_involved: false | shares_owned_after: 110,974.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 20,000 shares of Common Stock at $121.6 per share (Direct)
      Date: 2025-08-28 | Code: S | equity_swap_involved: false | shares_owned_after: 90,974.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 20,000 shares of Common Stock at $121.27 per share (Direct)
      Date: 2025-08-29 | Code: S | equity_swap_involved: false | shares_owned_after: 70,974.00 | transaction_form_type: 4 | Footnotes: F1, F5

    Footnotes:

    • F1: Represents the sale of underlying shares of previously exercised stock options.
    • F2: Such transaction was pursuant to a pre-approved 10b5-1 plan.
    • F3: Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $120.74 and $123.56.
    • F4: Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $120.75 and $122.47.
    • F5: Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $120.02 and $122.28.

Search

News categories